menu
    • menu

    Company profile for Neuvivo

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We are investigating a patented macrophage-targeted technology, NP001, designed to address chronic inflammation, a key factor in the progressive loss of motor function in ALS.To date, the treatment has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unme...
    Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We are investigating a patented macrophage-targeted technology, NP001, designed to address chronic inflammation, a key factor in the progressive loss of motor function in ALS.To date, the treatment has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuvivoUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    530 Lytton Ave, 2nd Fl, #214 Palo Alto, CA 94301
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neuvivo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuvivo/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuvivo Gains FDA Approval Pathway for NP001 ALS Treatment
    Neuvivo Gains FDA Approval Pathway for NP001 ALS Treatment

    30 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250730675720/en/Neuvivo-Reaches-Alignment-with-FDA-on-an-Approval-Pathway-for-NP001-to-Treat-ALS-and-Announces-the-Appointment-of-Biopharmaceutical-Expert-Dr.-John-Curnutte-to-Its-Board-of-Directors

    BUSINESSWIRE
    30 Jul 2025
    Share Share
    Neuvivo’s NP001 Extends Survival & Spares Lung Function In ALS
    Neuvivo’s NP001 Extends Survival & Spares Lung Function In ALS

    23 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250123661115/en

    BUSINESSWIRE
    23 Jan 2025
    Share Share
    Neuvivo Expands Board for Upcoming NDA Review with Robert Baffi
    Neuvivo Expands Board for Upcoming NDA Review with Robert Baffi

    29 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241029413001/en

    BUSINESSWIRE
    29 Oct 2024
    Share Share
    Breakthroughs In Preserving ALS Lung Function Unveiled In Studies
    Breakthroughs In Preserving ALS Lung Function Unveiled In Studies

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016426897/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment NP001
    Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment NP001

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241007056988/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Neuvivo Appoints Mark Henderson As VP Of Manufacturing
    Neuvivo Appoints Mark Henderson As VP Of Manufacturing

    22 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neuvivo-announces-mark-henderson-phd-as-vice-president-of-manufacturing-to-support-technical-operations-for-investigational-als-treatment-302227913.html

    PR NEWSWIRE
    22 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search